Plaguing humans for more than two millennia, manifest on every continent studied, and with more than one billion patients having an attack in any year, migraine stands as the sixth …
J Ailani, RC Burch, MS Robbins… - … : The Journal of …, 2021 - Wiley Online Library
Objective To incorporate recent research findings, expert consensus, and patient perspectives into updated guidance on the use of new acute and preventive treatments for …
Importance Approximately 90% of people in the US experience headache during their lifetime. Migraine is the second leading cause of years lived with disability worldwide …
Abstract Lasmiditan, a serotonin 5-HT1F receptor agonist, was effective for acute treatment of patients with migraine in a phase 3 double-blind randomized controlled study. The current …
Migraine is a common, chronic, disorder that is typically characterized by recurrent disabling attacks of headache and accompanying symptoms, including aura. The aetiology is …
RL Page, CL O'Bryant, D Cheng, TJ Dow, B Ky… - Circulation, 2016 - Am Heart Assoc
Heart failure is a common, costly, and debilitating syndrome that is associated with a highly complex drug regimen, a large number of comorbidities, and a large and often disparate …
AL Aguilar-Shea, JA Membrilla, J Diaz-de-Teran - Atencion primaria, 2022 - Elsevier
Migraine continues second among the world's causes of disability. Diagnosis is based on the history and clinical examination and imaging is usually not necessary. Migraine can be …
Migraine and stroke are two common and heterogeneous neurovascular disorders responsible for a significant burden for those affected and a great economic cost for the …
D Moreno-Ajona, MD Villar-Martínez… - Journal of clinical …, 2022 - mdpi.com
Migraine is a debilitating disease whose clinical and social impact is out of debate. Tolerability issues, interactions, contraindications, and inefficacy of the available …